Donoghue Forlines LLC Bristol Myers Squibb CO Transaction History

Donoghue Forlines LLC

$342 Million
Q3 2024

A detailed history of Donoghue Forlines LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Donoghue Forlines LLC holds 17,695 shares of BMY stock, worth $1.01 Million. This represents 0.27% of its overall portfolio holdings.

Number of Shares

17,695

Previous 16,746 5.67%

Holding current value

$1.01 Million

Previous $695,000 31.65%

% of portfolio

0.27%

Previous 0.2%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$39.66 - $51.75 $37,637 - $49,110	949 Added 5.67%	17,695 $915,000
Q2 2024 Aug 06, 2024	BUY	$40.25 - $52.99 $91,045 - $119,863	2,262 Added 15.62%	16,746 $695,000
Q1 2024 May 07, 2024	BUY	$47.98 - $54.4 $186,738 - $211,724	3,892 Added 36.74%	14,484 $785,000
Q4 2023 Feb 07, 2024	SELL	$48.48 - $57.85 $556,259 - $663,770	-11,474 Reduced 52.0%	10,592 $543,000
Q3 2023 Nov 06, 2023	BUY	$57.89 - $64.73 $351,450 - $392,975	6,071 Added 37.96%	22,066 $1.28 Million
Q2 2023 Aug 07, 2023	BUY	$63.71 - $70.74 $207,439 - $230,329	3,256 Added 25.56%	15,995 $1.02 Million
Q1 2023 May 08, 2023	SELL	$65.71 - $74.53 $1.47 Million - $1.67 Million	-22,421 Reduced 63.77%	12,739 $882,000
Q4 2022 Feb 08, 2023	BUY	$68.48 - $81.09 $1.38 Million - $1.63 Million	20,143 Added 134.13%	35,160 $2.53 Million
Q3 2022 Nov 07, 2022	SELL	$0.13 - $76.84 $2,942 - $1.74 Million	-22,638 Reduced 60.12%	15,017 $1.07 Million
Q2 2022 Aug 08, 2022	SELL	$72.62 - $79.98 $548,135 - $603,689	-7,548 Reduced 16.7%	37,655 $2.9 Million
Q1 2022 May 16, 2022	BUY	$61.48 - $73.72 $1.33 Million - $1.59 Million	21,557 Added 91.17%	45,203 $3.3 Million
Q4 2021 Feb 11, 2022	SELL	$53.63 - $62.52 $916,697 - $1.07 Million	-17,093 Reduced 41.96%	23,646 $1.47 Million
Q3 2021 Nov 15, 2021	SELL	$59.17 - $69.31 $40,413 - $47,338	-683 Reduced 1.65%	40,739 $2.41 Million
Q2 2021 Aug 16, 2021	SELL	$61.91 - $67.42 $21,049 - $22,922	-340 Reduced 0.81%	41,422 $2.77 Million
Q1 2021 May 14, 2021	BUY	$59.34 - $66.74 $1.08 Million - $1.21 Million	18,198 Added 77.23%	41,762 $2.64 Million
Q4 2020 Feb 09, 2021	BUY	$57.74 - $65.43 $200,184 - $226,845	3,467 Added 17.25%	23,564 $1.46 Million
Q3 2020 Nov 16, 2020	BUY	$57.43 - $63.64 $1.15 Million - $1.28 Million	20,097 New	20,097 $1.21 Million
Q2 2020 Aug 10, 2020	SELL	$54.82 - $64.09 $735,355 - $859,703	-13,414 Closed	0 $0
Q1 2020 May 12, 2020	SELL	$46.4 - $67.43 $1.76 Million - $2.56 Million	-37,944 Reduced 73.88%	13,414 $748,000
Q4 2019 Jan 27, 2020	SELL	$49.21 - $64.19 $1.84 Million - $2.4 Million	-37,345 Reduced 42.1%	51,358 $3.3 Million
Q3 2019 Oct 29, 2019	SELL	$42.77 - $50.71 $2.35 Million - $2.78 Million	-54,870 Reduced 38.22%	88,703 $4.5 Million
Q2 2019 Jul 23, 2019	BUY	$44.62 - $49.34 $6.41 Million - $7.08 Million	143,573 New	143,573 $6.51 Million

Others Institutions Holding BMY

# of Institutions

2,536

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $122B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Donoghue Forlines LLC, based on Form 13F filings with the SEC.

News

Stay updated on Donoghue Forlines LLC with notifications on news.

Account

Donoghue Forlines LLC Bristol Myers Squibb CO Transaction History